Hodgkin Lymphoma:グローバル臨床試験レビューH2, 2013...市場調査レポートについてご紹介

【英文タイトル】Hodgkin Lymphoma Global Clinical Trials Review, H2, 2013

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Hodgkin Lymphoma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by G7 Nations 16
Clinical Trials in G7 Nations by Trial Status 17
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Hodgkin Lymphoma 25
Subjects Recruited Over a Period of Time 33
Prominent Sponsors 34
Top Companies Participating in Hodgkin Lymphoma Therapeutics Clinical Trials 36
Prominent Drug Comparison 38
Clinical Trial Profiles 39
Clinical Trial Overview of Top Companies 39
Seattle Genetics, Inc. 39
Clinical Trial Overview of Seattle Genetics, Inc. 39
Takeda Pharmaceutical Company Limited 41
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 41
Novartis AG 43
Clinical Trial Overview of Novartis AG 43
Amgen Inc. 45
Clinical Trial Overview of Amgen Inc. 45
Sanofi 47
Clinical Trial Overview of Sanofi 47
Bristol-Myers Squibb Company 49
Clinical Trial Overview of Bristol-Myers Squibb Company 49
Celgene Corporation 50
Clinical Trial Overview of Celgene Corporation 50
Merck & Co., Inc. 51
Clinical Trial Overview of Merck & Co., Inc. 51
Pharmacyclics, Inc. 52
Clinical Trial Overview of Pharmacyclics, Inc. 52
Clinical Trial Overview of Top Institutes / Government 53
National Cancer Institute 53
Clinical Trial Overview of National Cancer Institute 53
Fred Hutchinson Cancer Research Center 65
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 65
The University of Texas M. D. Anderson Cancer Center 68
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 68
Memorial Sloan Kettering Cancer Center 70
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 70
University of Cologne 72
Clinical Trial Overview of University of Cologne 72
Children’s Oncology Group 74
Clinical Trial Overview of Children’s Oncology Group 74
Baylor College of Medicine 76
Clinical Trial Overview of Baylor College of Medicine 76
Stanford University 78
Clinical Trial Overview of Stanford University 78
Dana-Farber Cancer Institute, Inc. 79
Clinical Trial Overview of Dana-Farber Cancer Institute, Inc. 79
Cancer Research UK 80
Clinical Trial Overview of Cancer Research UK 80
Five Key Clinical Profiles 81
Appendix 120
Abbreviations 120
Definitions 120
Research Methodology 121
Secondary Research 121
About GlobalData 122
Contact Us 122
Disclaimer 122
Source 123


【レポート販売概要】

■ タイトル:Hodgkin Lymphoma:グローバル臨床試験レビューH2, 2013
■ 英文:Hodgkin Lymphoma Global Clinical Trials Review, H2, 2013
■ 発行日:2013年11月30日
■ 調査会社:GlobalData
■ 商品コード:GDATA403162871
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。